Evidence map›Paper›PMID 27267136›Full record

ArticleBiochemistry2016

Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.

Inacrist Geronimo, Catherine A Denning, W Eric Rogers, Thaer Othman, Tom Huxford, David K Heidary, Edith C Glazer, Christina M Payne

Abstract read
In one paragraph

Article in Biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Production of metabolites of the anti-cancer drug noscapine using a P450Biotechnology reports (Amsterdam, Netherlands) · 2019
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Inacrist GeronimoDepartment of Chemical and Materials Engineering, University of Kentucky , Lexington, Kentucky 40506-0046, United States.
Catherine A DenningDepartment of Chemistry, University of Kentucky , Lexington, Kentucky 40506-0055, United States.
W Eric RogersStructural Biochemistry Laboratory, Department of Chemistry & Biochemistry, San Diego State University , San Diego, California 92182-1030, United States.
Thaer OthmanStructural Biochemistry Laboratory, Department of Chemistry & Biochemistry, San Diego State University , San Diego, California 92182-1030, United States.
Tom HuxfordStructural Biochemistry Laboratory, Department of Chemistry & Biochemistry, San Diego State University , San Diego, California 92182-1030, United States.
David K HeidaryDepartment of Chemistry, University of Kentucky , Lexington, Kentucky 40506-0055, United States.
Edith C GlazerDepartment of Chemistry, University of Kentucky , Lexington, Kentucky 40506-0055, United States.
Christina M PayneDepartment of Chemical and Materials Engineering, University of Kentucky , Lexington, Kentucky 40506-0046, United States.

Funding

Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
Pixel Array Detector for X-ray CrystallographyS10RR029205 · NCRR · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2010 to 2010
$1.8M
NCRR NIH HHS S10 RR029205NIDA NIH HHS T32 DA016176NIGMS NIH HHS P41 GM103403
6 · The paper itself

Abstract

Cytochrome P450BM3 is a heme-containing enzyme from Bacillus megaterium that exhibits high monooxygenase activity and has a self-sufficient electron transfer system in the full-length enzyme. Its potential synthetic applications drive protein engineering efforts to produce variants capable of oxidizing nonnative substrates such as pharmaceuticals and aromatic pollutants. However, promiscuous P450BM3 mutants often exhibit lower stability, thereby hindering their industrial application. This study demonstrated that the heme domain R47L/F87V/L188Q/E267V/F81I pentuple mutant (PM) is destabilized because of the disruption of hydrophobic contacts and salt bridge interactions. This was directly observed from crystal structures of PM in the presence and absence of ligands (palmitic acid and metyrapone). The instability of the tertiary structure and heme environment of substrate-free PM was confirmed by pulse proteolysis and circular dichroism, respectively. Binding of the inhibitor, metyrapone, significantly stabilized PM, but the presence of the native substrate, palmitic acid, had no effect. On the basis of high-temperature molecular dynamics simulations, the lid domain, β-sheet 1, and Cys ligand loop (a β-bulge segment connected to the heme) are the most labile regions and, thus, potential sites for stabilizing mutations. Possible approaches to stabilization include improvement of hydrophobic packing interactions in the lid domain and introduction of new salt bridges into β-sheet 1 and the heme region. An understanding of the molecular factors behind the loss of stability of P450BM3 variants therefore expedites site-directed mutagenesis studies aimed at developing thermostability.

Indexed as

Bacillus megateriumBacterial ProteinsBinding SitesCircular DichroismCrystallizationCrystallography, X-RayCytochrome P-450 Enzyme SystemElectron TransportEnzyme InhibitorsHydroxylationKineticsMetyraponeModels, MolecularMutagenesis, Site-DirectedMutant ProteinsMutationBacterial ProteinsCytochrome P-450 Enzyme SystemEnzyme Inhibitorsflavocytochrome P450 BM3 monoxygenasesMetyraponeMutant ProteinsNADPH-Ferrihemoprotein ReductasePalmitic Acid

Identifiers

PMID27267136
PMCPMC7422958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.